This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Abbvie Biotherapeutics Inc.. Active years: 2018-2020.
Company Filing History:
Years Active: 2018-2020
Title: The Innovations of Daniel E H Afar
Introduction
Daniel E H Afar is a notable inventor based in Los Altos Hills, California. He has made significant contributions to the field of biotherapeutics, particularly in the development of anti-PD-1 antibodies. With a total of 2 patents to his name, his work has the potential to impact cancer treatment and immunotherapy.
Latest Patents
His latest patents include innovative anti-PD-1 antibodies and their uses. The present disclosure provides novel anti-PD-1 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same. These advancements are crucial in the ongoing battle against cancer, offering new avenues for treatment.
Career Highlights
Daniel E H Afar is currently associated with AbbVie Biotherapeutics Inc., where he continues to push the boundaries of medical science. His work at AbbVie has positioned him as a key player in the biopharmaceutical industry, focusing on developing therapies that can enhance patient outcomes.
Collaborations
Some of his notable coworkers include Fiona A Harding and Josue Samayoa. Their collaborative efforts contribute to the innovative environment at AbbVie, fostering advancements in therapeutic solutions.
Conclusion
Daniel E H Afar's contributions to the field of biotherapeutics, particularly through his patents on anti-PD-1 antibodies, highlight his role as an influential inventor. His work not only showcases his expertise but also promises to make a significant impact on cancer treatment in the future.